| Stage | CHTR | % of rev | IFF | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $13.5B | 100.00% | $2.0B | 100.00% | CHTR ×6.92 |
| Gross profit | $13.5B | 100.00% | $853M | 43.65% | CHTR +56.3pp |
| Operating income | $3.1B | 22.65% | $158M | 8.09% | CHTR +14.6pp |
| Pre-tax income | $2.0B | 14.78% | $64M | 3.28% | CHTR +11.5pp |
| Net income | $1.5B | 11.27% | $51M | 2.61% | CHTR +8.7pp |
| Stage | CHTR | IFF | Gap · A − B |
|---|---|---|---|
| Revenue | $13.5B100.00% | $2.0B100.00% | CHTR ×6.92 |
| Gross profit | 100.00%$13.5B | 43.65%$853M | CHTR +56.3pp |
| Operating income | 22.65%$3.1B | 8.09%$158M | CHTR +14.6pp |
| Pre-tax income | 14.78%$2.0B | 3.28%$64M | CHTR +11.5pp |
| Net income |
| 11.27%$1.5B |
| 2.61%$51M |
| CHTR +8.7pp |
No shared counterparties.